Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

uniQure N.V.

Complete analysis of the HOPE-B safety event and submit it to the FDA

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
1 Mar 2021
Due
31 Mar 2021
Delivered
26 Mar 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Analysis of the HOPE-B safety event expected to be completed and submitted to the FDA before end of the first quarter of 2021”
  • SourceuniQure N.V. Form 8-K press release, 2021-03-01
  • FilingSEC filing index
  • Deadline as statedbefore end of the first quarter of 2021
  • Deadline used31 Mar 2021, the last day of the stated period
  • TypeRegulatory
  • Permanent referenceKI-C-2021-QURE-024797
    Cite as https://keptindex.org/c/KI-C-2021-QURE-024797/ — this address never changes.

What we found

Evidence strength A What the grades mean

Later filings state the HOPE-B HCC investigation results were submitted to the FDA on March 26, 2021, before the March 31, 2021 deadline.

  • A
    uniQure N.V. 8-K filed 2021-04-01 Regulatory filing · published 1 Apr 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC · fingerprint 4e48114f1961
    “Data from investigation submitted to U.S Food and Drug Administration (FDA) on March 26, 2021” ✓ confirmed on the page
  • A
    uniQure N.V. 10-Q filed 2021-05-10 Regulatory filing · published 10 May 2021 · retrieved 26 Oct 2026 · kept permanently by the SEC · fingerprint e814dbf93d61
    “On March 26, 2021, we submitted the results of a comprehensive investigation into the case of HCC to the FDA.” ✓ confirmed on the page

Checked 26 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Regulatory other
Indicative materiality
Medium rules
Action
Complete
Deliverable
HOPE-B safety event analysis submitted to FDA
Language
Aspirational (“aims”, “intends”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you uniQure N.V.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-QURE-024797 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.